Episode 42: Darnisha Harrison - Using Therapeutics to Tackle COVID-19

LSU Experimental

Contenido proporcionado por LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

3+ y ago 41:51

MP3•Episodio en casa

COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/

5 episodios

#LSU Experimental #LSU College of Science #LSU Communication across the Curriculum #Podcasting Education